New Technology Can Break The Blood-Brain Barrier To Directly Treat Brain Tumours, Is Potent And Less Toxic, And Deserves Attention!
Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment!
Major Breakthrough In 27 Years! This Cancer Vaccine Has Kept Deadly Brain Cancer Patients Alive For Over 8 Years!
Approved! With Just One Oral Dose Per Day, This Type Of Breast Cancer Patient Gets a New Drug
University of Tokyo Hospital - Top 10 Best Hospitals in the World
US National Children's Hospital
